Search results
Results from the WOW.Com Content Network
Anne E. Wojcicki (/ w uː ˈ tʃ ɪ t s k i / woo-CHITS-kee; [2] born July 28, 1973) is an American entrepreneur who co-founded and is CEO of the personal genomics company 23andMe. She founded the company in 2006 with Linda Avey and Paul Cusenza. She is a co-founder and board member of the Breakthrough Prize.
Genetic testing firm 23andMe said on Monday it is reducing about 40%, or 200 employees, from its workforce and discontinuing further development of all its therapies as part of a restructuring ...
Despite 23andMe’s bleak prognosis, Wojcicki, who has helmed the company since its 2006 founding, has not given up. “I think we can navigate and land this plane,” she told Fortune last month ...
The resignations follow drawn-out negotiations with 23andMe CEO and co-founder Anne Wojcicki, who wants to take the company private. In a Tuesday letter addressed to Wojcicki, the seven directors ...
Anne Wojcicki and her genetic sequencing company 23andMe are locked in a battle with the FDA. Even though it can't report results to customers right now, Wojcicki isn't letting herself get bogged ...
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California. [1] It is best known for providing a direct-to-consumer genetic testing service in which customers provide a saliva sample that is laboratory analysed, using single nucleotide polymorphism genotyping, [2] to generate reports relating to the customer's ancestry and genetic ...
In March 2006 Avey, Anne Wojcicki, and Paul Cusenza founded 23andMe, [8] [9] [10] "one of the first, and only, [clarification needed] companies to offer genetic profiles directly to consumers, rather than through doctors or researchers". [11] Avey left the company in 2009. [12] Cusenza had left the company in 2007. [citation needed]
23andMe CEO Anne Wojcicki co-founded the company in 2006 with biologist Linda Avey and Paul Cusenza, who previously worked at the now-defunct Perlegen Sciences, which was a biotech startup that ...